id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-D-5580-0001,FDA,FDA-2024-D-5580,M15 General Principles for Model- Informed Drug Development; International Council for Harmonisation; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T16:48:34Z,2024-31027,0,0,0900006486894ec6
FDA-2024-D-5580-0002,FDA,FDA-2024-D-5580,M15 General Principles for Model-Informed Drug Development; International Council for Harmonisation - Draft Guidance,Other,Guidance,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-03-01T04:59:59Z,2025-03-04T02:00:45Z,,1,0,09000064868955df